Cemex SAB de CV ADR (CX) Stock Forecast & Price Target
Cemex SAB de CV ADR · NYSE
$11.99-0.20 (-1.68%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering Cemex SAB de CV ADR, 6 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $10.00 to $16.00, a moderate spread. The average target of $13.10 sits 9% above the current $11.99. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.17 next quarter toward $0.92 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Moderate Buy
Strong Buy00%
Buy675%
Hold225%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to Cemex SAB de CV ADR.
As of Jul, 6 of 8 firms rate CX a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CX EPS & revenue forecast
EPS · NEXT QUARTER
$0.17
Range $0.17 – $0.17 · 1 analysts
Next period, 1 analysts expect Cemex SAB de CV ADR to earn $0.17 a share (range $0.17 – $0.17), versus — a year earlier. Full-year consensus is $0.83, growing to $0.92 the year after.
REVENUE · NEXT QUARTER
$4.3B
Range $4.2B – $4.4B · 1 analysts · +3% YoY
Revenue is expected to reach $4.3B (range $4.2B – $4.4B), +2.7% year-over-year. Full-year consensus is $17.4B, rising to $18.0B next year.
Top analysts covering Cemex SAB de CV ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CX.
#1
Benjamin Theurer
Barclays · Rank #72
Buy
$16.00+33.4% to target
Overall win rate
47%
+ Follow
#2
Bruno Amorim
Goldman Sachs · Rank #265
Buy
$11.00-8.3% to target
Overall win rate
33%
+ Follow
#3
AC
Anthony Codling
RBC Capital
Hold
$13.50+12.5% to target
Coverage
—
+ Follow
#4
FS
Francisco Suarez
Scotiabank
Buy
$14.50+20.9% to target
Coverage
—
+ Follow
#5
AH
Adrian Huerta
JP Morgan
Buy
$15.00+25.1% to target
Coverage
—
+ Follow
CX stock forecast FAQ
What is CX's average 12-month price target?+
The 8 analysts with a live target average $13.10 for Cemex SAB de CV ADR over the next 12 months, ranging from a $16.00 high to a $10.00 low.
Is CX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 8 analyst ratings, 6 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CX?+
The Street-high target is $16.00 (Barclays), and the Street-low is $10.00 (Citigroup). The average of all 8 active targets is $13.10.
How many Wall Street analysts cover CX?+
8 analysts have an active rating on Cemex SAB de CV ADR, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering CX?+
Among analysts who currently cover CX, Benjamin Theurer of Barclays has the strongest overall Quantellect track record (Rank #72). Their current call is Buy with a $16.00 target.
What is Cemex SAB de CV ADR's projected EPS for next quarter?+
The consensus estimate is $0.17 per share (range $0.17 – $0.17) across 1 analysts. Full-year EPS is projected at $0.83, rising to $0.92 the following year.
How much revenue is Cemex SAB de CV ADR expected to report next quarter?+
Consensus revenue is $4.3B (range $4.2B – $4.4B). Full-year revenue is projected at $17.4B, growing to $18.0B next year.
Have analysts been upgrading or downgrading CX lately?+
As of Jul, 6 of 8 firms rate CX a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
